XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Class A Common Stock, Class B Common Stock and Class C Capital Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Accumulated Deficit
Accumulated Deficit
Cumulative-effect adjustment from adoption of guidance on accounting for convertible instruments and contracts in an entity’s own equity
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2019 $ 3,435   $ 0 $ 4,412   $ (977)   $ 0
Beginning Balance (in shares) at Dec. 31, 2019     209,067          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common and capital stock upon exercise of stock options 444     444        
Issuance of common and capital stock upon exercise of stock options (in shares)     13,745          
Vesting of restricted stock units (in shares)     3,013          
Share-based compensation expense 214     214        
Issuance of Class C capital stock in connection with equity offering, net of issuance costs 412     412        
Issuance of Class C capital stock in connection with equity offering, net of issuance costs (in shares)     8,800          
Equity component of issuance of convertible senior notes maturing in 2025, net of issuance costs 155     155        
Settlement of convertible senior notes 244     244        
Settlement of convertible senior notes (in shares)     6,219          
Unwind of Capped Call Transactions     (318)          
Unwind of capped call transactions (162)         (162)    
Other comprehensive income 0              
Ending Balance at Dec. 31, 2020 4,742   $ 0 5,881   (1,139)   0
Ending Balance (in shares) at Dec. 31, 2020     240,526          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common and capital stock upon exercise of stock options 127     127        
Issuance of common and capital stock upon exercise of stock options (in shares)     3,304          
Vesting of restricted stock units (in shares)     2,982          
Restricted stock units withheld for tax liability (in shares)     (1)          
Share-based compensation expense 347     347        
Issuance of Class C capital stock in connection with equity offering, net of issuance costs 545     545        
Issuance of Class C capital stock in connection with equity offering, net of issuance costs (in shares)     3,164          
Settlement of convertible senior notes 403     403        
Settlement of convertible senior notes (in shares)     6,265          
Unwind of Capped Call Transactions     (666)          
Repurchases of Class A common stock and Class C capital stock (302)     (302)        
Repurchases of Class A common stock and Class C capital stock (in shares)     (4,944)          
Unwind of capped call transactions (528)         (528)    
Other comprehensive income 7             7
Ending Balance at Dec. 31, 2021 5,341 $ (336) $ 0 7,001 $ (492) (1,667) $ 156 7
Ending Balance (in shares) at Dec. 31, 2021     250,630          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common and capital stock upon exercise of stock options $ 45     45        
Issuance of common and capital stock upon exercise of stock options (in shares) 1,129   1,129          
Vesting of restricted stock units (in shares)     4,722          
Share-based compensation expense $ 502     502        
Repurchases of Class A common stock and Class C capital stock (947)     (947)        
Repurchases of Class A common stock and Class C capital stock (in shares)     (22,213)          
Unwind of capped call transactions (101)         (101)    
Other comprehensive income (22)             (22)
Ending Balance at Dec. 31, 2022 $ 4,482   $ 0 $ 6,109   $ (1,612)   $ (15)
Ending Balance (in shares) at Dec. 31, 2022     234,268